ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.19 | 33,351 | 173,092 | 116,116 | |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 52.13 | 3,450 | 179,849 | 384,223 | 387.7 K to 384.2 K (-0.89 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 51.11 | 10,680 | 545,855 | 387,673 | 398.4 K to 387.7 K (-2.68 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 49.98 | 2,800 | 139,944 | 398,353 | 401.2 K to 398.4 K (-0.70 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 49.07 | 10,554 | 517,885 | 401,153 | 411.7 K to 401.2 K (-2.56 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 47.93 | 6,432 | 308,286 | 411,707 | 418.1 K to 411.7 K (-1.54 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 47.07 | 6,397 | 301,107 | 418,139 | 424.5 K to 418.1 K (-1.51 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.19 | 33,351 | 173,092 | 424,536 | 391.2 K to 424.5 K (+8.53 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 60.99 | 1,300 | 79,287 | 858,993 | 860.3 K to 859 K (-0.15 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 60.37 | 22,466 | 1,356,272 | 860,293 | 882.8 K to 860.3 K (-2.54 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 59.57 | 11,847 | 705,726 | 882,759 | 894.6 K to 882.8 K (-1.32 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 61.02 | 100 | 6,102 | 258,375 | 258.5 K to 258.4 K (-0.04 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 60.43 | 8,931 | 539,700 | 258,475 | 267.4 K to 258.5 K (-3.34 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 59.61 | 5,594 | 333,458 | 267,406 | 273 K to 267.4 K (-2.05 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 60.95 | 500 | 30,475 | 391,185 | 391.7 K to 391.2 K (-0.13 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 60.40 | 11,907 | 719,183 | 391,685 | 403.6 K to 391.7 K (-2.95 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 59.60 | 7,593 | 452,543 | 403,592 | 411.2 K to 403.6 K (-1.85 %) |